|
Science correspondent Embryonic stem cell research has generated much discussion worldwide despite the fact that it has not yet yielded concrete applications for human therapy. Gov. Jon Corzine signed legislation two months ago authorizing $270 million towards human embryonic stem cell research in New Jersey. This has opened up many doors to scientific breakthroughs and also stimulated much new discussion on the controversial topic. In response to the New Jersey legislation, Hadassah, the Women’s Zionist Organization of America, is presenting a program to address the latest breakthroughs and controversies in stem cell research. A Hadassah Young Leaders event, scheduled for March 15 at the Montclair Art Museum, will tackle the issues generated by this provocative technology. Barry Schindler, of Mountain Lakes, a patent attorney with Greenberg Traurig, LLP, which supports firms pursuing stem cell research, will speak about the legal barriers. He will be joined by Dr. Gary Friedman, a nephrologists, transplant specialist, and founding trustee of the New Jersey Stem Cell Research and Education Foundation, who will talk about therapeutic applications of the technology.
|